InMed Pharmaceuticals Inc. (INM)

NASDAQ: INM · Real-Time Price · USD

0.8857

-0.0343 (-3.73%)

At close: Mar 9, 2026, 4:00 PM EDT

0.7900

-0.0957 (-10.81%)

After-hours: Mar 9, 2026, 7:55 PM EDT

InMed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	6.95	11.08	6.57	8.91	6.18	7.36
Short-Term Investments	0.04	0.04	0.04	0.04	0.04	0.05
Cash & Short-Term Investments	7	11.12	6.61	8.96	6.22	7.41
Cash Growth	102.23%	68.10%	-26.15%	43.96%	-16.03%	26.70%
Accounts Receivable	0.18	0.47	0.35	0.26	0.1	0.01
Inventory	0.95	0.96	1.24	1.62	2.49	-
Other Current Assets	0.66	0.32	0.48	0.5	0.8	0.96
Total Current Assets	8.79	12.87	8.69	11.33	9.6	8.38
Net Property, Plant & Equipment	0.76	0.99	1.25	0.72	0.9	0.33
Other Intangible Assets	1.54	1.62	1.78	1.95	2.11	1.06
Other Long-Term Assets	0.1	0.1	0.1	0.1	0.18	0.01
Total Assets	11.19	15.58	11.82	14.11	12.79	9.78
Accounts Payable	1.07	1.4	1.65	1.61	2.42	2.13
Current Portion of Leases	0.41	0.44	0.32	0.38	0.4	0.08
Other Current Liabilities	-	-	-	0.02	0.5	-
Total Current Liabilities	1.48	1.84	1.97	2	3.32	2.22
Long-Term Leases	0.12	0.31	0.64	0.02	0.39	0.19
Total Long-Term Liabilities	0.12	0.31	0.64	0.02	0.39	0.19
Total Liabilities	1.6	2.15	2.62	2.02	3.71	2.4
Common Stock	92.05	91.22	82.78	77.62	70.72	60.39
Additional Paid-in Capital	38.41	39.32	35.37	35.74	31.68	21.51
Accumulated Other Comprehensive Income	0.13	0.13	0.13	0.13	0.13	0.13
Retained Earnings	-120.99	-117.24	-109.06	-101.4	-93.45	-74.65
Total Common Shareholders' Equity	9.59	13.43	9.23	12.09	9.08	7.38
Shareholders' Equity	9.59	13.43	9.21	12.09	9.08	7.38
Total Liabilities & Equity	11.19	15.58	11.82	14.11	12.79	9.78
Total Debt	0.53	0.74	0.96	0.39	0.79	0.27
Net Cash (Debt)	6.47	10.38	5.65	8.57	5.43	7.14
Net Cash Growth	-37.70%	83.62%	-34.01%	57.80%	-23.98%	35.14%
Net Cash Per Share	1.64	10.63	14.83	69.97	173.66	531.25
Book Value	9.59	13.43	9.23	12.09	9.08	7.38
Book Value Per Share	2.43	13.77	24.21	98.75	290.47	548.87
Tangible Book Value	8.05	11.81	7.44	10.14	6.97	6.31
Tangible Book Value Per Share	2.04	12.11	19.53	82.86	222.99	469.88

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q